Literature DB >> 12693237

Molecular, 1D, and 2D systems built from phenylcyanamido ligands. Syntheses, crystal structures, and characterization of their magnetic properties.

Albert Escuer1, Núria Sanz, Ramon Vicente, Franz A Mautner.   

Abstract

Several MnII compounds with phenylcyanamido ligands have been synthesized and characterized by means of single-crystal X-ray structural determination. The reported compounds show a wide variety of nuclearity from mononuclear and dinuclear systems to 1D chains and 2D networks in which X-phenylcyanamide (X-pcyd) anions act as the bridging ligand. Mononuclear compound [Mn(H2O)2(4-bzpy)2(3-Cl- pcyd)2] (2) crystallizes in the monoclinic system, P21/a space group, dinuclear compounds (mu 1,3-3-Cl-pcyd)2[Mn(2,2'-bpy)(3-Cl-pcyd)(MeOH)]2 (2) and (mu 1,3-3-Cl-pcyd)2[Mn(2,2'-bpy)(3-Cl-pcyd)(EtOH)]2 (3) crystallize in the triclinic system, P1 space group, 1D chain [(mu 1,3-4-Cl-pcyd)2[Mn(2,2'-bpy)]]n (4) crystallizes in the monoclinic system, /2/a space group, and 2D network [Mn(mu-4,4'-bpy)(mu 1,3-3-F-pcyd)2]n (5) crystallizes in the monoclinic system, C2 space group. Susceptibility measurements on compounds 2-4 reveal moderate antiferromagnetic coupling in all cases. MO calculations have been made to elucidate the main factors that control the superexchange pathway for this kind of ligand. Comparison of their magnetic behavior with that of related ligands such as azido and dicyanamido is reported.

Entities:  

Year:  2003        PMID: 12693237     DOI: 10.1021/ic025931l

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  catena-Poly[[(dimethyl-formamide-κO)cobalt(II)]-bis-[μ-(4-nitro-phenyl)-cyanamido]-κN:N;κN:N].

Authors:  Hossein Chiniforoshan; Bahare Shirinfar; Soghra Jalilpour; Hamid Reza Khavasi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-24

2.  Normal coordinate analyses of 3,5-dichlorophenylcyanamide.

Authors:  Hassan M Badawi; Wolfgang Förner
Journal:  J Mol Model       Date:  2004-03-16       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.